NCT Number: NCT03522311
Surgical Outcomes for Proliferative Diabetic Retinopathy by Preoperative Glycemic Control and Renal Function
The surgical outcomes of 25-gauge vitrectomy for proliferative diabetic retinopathy has been evaluated by preoperative glycemic control and renal function
Looking for future studies?
Notify MeKey information
Conditions
Age range
10 year–90 year
Sex eligibility
All sexes
Study type
Observational
About this study
The purpose of this study is to evaluate the surgical outcomes of 25-gauge vitrectomy for proliferative diabetic retinopathy by preoperative glycemic control and renal function.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- The patients had25-gauge vitrectomy for proliferative diabetic retinopathy
Exclusion criteria
- The patients had hemodialysis , followed up less than 6 months, had vitrectomy for diabetic macular edema and macular ration but not macular detachment.
Treatment and study plan
Primary outcomes
-
Visual acuity measurement
Time frame: 6 months
Visual acuity improvement from baseline
Secondary outcomes
-
Presence of postoperative vitreous hemorrhage
Time frame: 6 months
Incidence of postoperative vitreous hemorrhage
Other outcomes
-
Presence of postoperative retinal detachment
Time frame: 6 months
Incidence of postoperative retinal detachment
Sponsors and collaborators
Lead sponsor
Kyorin University
Other
Registry information
Official study title
Evaluation of 25-gauge Vitrectomy Surgical Outcomes for Proliferative Diabetic Retinopathy by Preoperative Glycemic Control and Renal Function
Important dates
- Study start
- 2013
- Primary completion
- 2016
- Study completion
- 2016
- First posted
- May 11, 2018
- Registry last updated
- May 11, 2018
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Pain Management During Panretinal Photocoagulation for Diabetic Retinopathy: Safety and Efficacy of Peribulbar Anesthesia
NCT07640256
Agnosia, Nervous System Diseases
Mexico City, Mexico
View Trial DetailsGenetic Markers and Proliferative Diabetic Retinopathy
NCT02879422
Proliferative Diabetic Retinopathy
Reims, France
View Trial DetailsStudy of Efficacy and Safety of Brolucizumab Versus Panretinal Photocoagulation Laser in Patients With Proliferative Diabetic Retinopathy
NCT04278417
Eye Diseases, Metaplasia
Tucson, Arizona, United States
View Trial DetailsBiological Changes in Fibrovascular Membranes of Patients With Proliferative Diabetic Retinopathy Following Faricimab Injection
NCT07144865
Proliferative Diabetic Retinopathy
Tianjin, Tianjin Municipality, China
View Trial Details